Arcadia Biosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $12.7M | $43.9M | $28.7M |
| FY2022 | $8.0M | $28.9M | $20.6M |
| FY2023 | $7.0M | $19.7M | $6.5M |
| FY2024 | $7.3M | $13.5M | $4.2M |
| FY2025 | $2.4M | $6.5M | $259.0K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $12.7M | $43.9M | $28.7M |
| FY2022 | $8.0M | $28.9M | $20.6M |
| FY2023 | $7.0M | $19.7M | $6.5M |
| FY2024 | $7.3M | $13.5M | $4.2M |
| FY2025 | $2.4M | $6.5M | $259.0K |